Abiopharma

🔍 Llorca Jesus (Executive)

Company: SEACOR Marine Holdings Inc. (SMHI)

Report Date: 2026-06-29

Detailed Transactions and Holdings:

• Sold 14,461 shares of Common Stock at $8.03 per share (Direct)
  Date: 2026-06-29 | Code: S | equity_swap_involved: false | shares_owned_after: 497,406.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 1,649 shares of Common Stock at $8.02 per share (Direct)
  Date: 2026-06-30 | Code: S | equity_swap_involved: false | shares_owned_after: 495,757.00 | transaction_form_type: 4 | Footnotes: F3, F4

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
• F2: The reported sale of 14,461 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
• F4: The reported sale of 1,649 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026.